China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

The Hedge Fund Toolkit Behind the Yen Intervention
17:49

Our Town Chapter 1: Sometimes You Find Silver
45:02

The Situation at Situational Awareness
18:35